CMD News and Press, Cantel Medical Corp. From 05/26/21

Agilent price target raised by analysts after better than expected Q2 resultsSeveral firms have lifted the price target for Agilent Technologies (A) after the company raised the fiscal 2021 guidance and reported better-than-expected Q2 FY21 earnings. Agilent has added ~5.1% in ...

The EON™ Portable Dialysis Water System produces high-quality medical water for acute and home hemodialysis use Mar Cor Purification, Inc., a Cantel Medical Corp. (NYSE: CMD ) business, announces the launch of the EON™ Portable Dialysis Water System. The po...

Merger activity increased last week with seven new deals announced. 24 deals announced in the month of April. The acquisition of Proofpoint by Thoma Bravo. For further details see: Merger Arbitrage Mondays - Standard Industries Finally Bags W. R. Grace

Shares of Cantel Medical Corp. (NYSE:CMD) traded at a new 52-week high today of $89.50. So far today approximately 66,000 shares have been exchanged, as compared to an average 30-day volume of 472,000 shares. Cantel Medical Corp. (NYSE:CMD) is currently priced 70.2% above its average con...

Declining SPAC IPOs could indicate the SPAC bubble may have run its course. Brookfield Asset Management agrees to acquire Brookfield Property Partners after increasing its bid by 10%. Aggregate deal value in a highly competitive M&A space approaches $600 billion in Q1 202...

Cantel Medical Corp. (CMD) Q2 2021 Earnings Conference Call March 9, 2021 8:30 AM ET Company Participants Ryan Lada - VP, Investor Relations George Fotiades - Chief Executive Officer Charles Diker - Chairman Shaun Blakeman - Senior Vice President and Chief Financial Officer Peter Clifford - P...

The following slide deck was published by Cantel Medical Corp. in conjunction with their 2021 Q2 earnings call. For further details see: Cantel Medical Corp. 2021 Q2 - Results - Earnings Call Presentation

Cantel Medical (CMD): FQ2 Non-GAAP EPS of $0.79 beats by $0.29; GAAP EPS of $0.27 misses by $0.11.Revenue of $294.04M (+1.9% Y/Y) beats by $17.41M.Press Release For further details see: Cantel Medical EPS beats by $0.29, beats on revenue

Cantel Medical Reports Strong Financial Results for its Second Quarter Fiscal Year 2021 Demand for Medical and Dental IP&C solutions continue to outpace elective procedure volume Strong recurring revenue mix and continued cost discipline driving higher profitability ...

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2021 PR Newswire LITTLE FALLS, N.J. , Feb. 25, 2021 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its second quarter ended...